ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $783,069 | -31.5% | 261,023 | -14.6% | 0.00% | – |
| Q2 2023 | $1,143,397 | +21.9% | 305,721 | +9.2% | 0.00% | – |
| Q1 2023 | $938,201 | -19.8% | 280,060 | +15.1% | 0.00% | – |
| Q4 2022 | $1,169,874 | -14.5% | 243,217 | +1.2% | 0.00% | – |
| Q3 2022 | $1,368,000 | -15.2% | 240,384 | +5.8% | 0.00% | – |
| Q2 2022 | $1,613,000 | +10.8% | 227,220 | +12.7% | 0.00% | – |
| Q1 2022 | $1,456,000 | -41.7% | 201,693 | -27.9% | 0.00% | – |
| Q4 2021 | $2,499,000 | -90.0% | 279,568 | -60.8% | 0.00% | -100.0% |
| Q3 2021 | $25,006,000 | +206.2% | 713,225 | +87.6% | 0.01% | +150.0% |
| Q2 2021 | $8,167,000 | -48.0% | 380,224 | +49.6% | 0.00% | -50.0% |
| Q1 2021 | $15,696,000 | +54.2% | 254,188 | +4.3% | 0.00% | +33.3% |
| Q4 2020 | $10,179,000 | – | 243,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |